On 29 July 2020, Meyer Burger Technology AG completed a capital increase comprising a rights offering to its shareholders and a private placement to selected investors, resulting in gross proceeds of approximately CHF 165 million. Meyer Burger intends
Tags :Marvin Kanku
On 28 July 2020, Basilea Pharmaceutica completed the offering of approximately CHF 97 million 3.25% convertible bonds due 2027 to finance the repurchase of a part of Basilea’s existing convertible bonds due 2022. With the repurchase of part of its
Deutsche Börse Group’s post-trade services provider Clearstream and Ubs have agreed on a partnership in the investment fund services business segment.
Waters Corporation announced to acquire Andrew Alliance, a Switzerland-based innovator in specialty laboratory automation technology
